Amiodarone Hydrochloride | US Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Amiodarone Hydrochloride
US Patents

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

Contact Supplier

xyz-pharma-m-2025-03-24

Contact Supplier

LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

Contact Supplier

Gentec Pharmaceutical Group is focused on manufacturing & developing APIs/HPAPIs, Advanced Intermediates & Fine Chemicals.

Contact Supplier

xyz-pharma-m-2025-03-17

Contact Supplier

Amiodarone Hydrochloride

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

34 API Suppliers, 10 USDMF, 12 CEP/COS, 2 JDMF, 6 EU WC, 2 KDMF, 8 NDC API, 25 Listed Suppliers, $ API Reference Price

34 API Suppliers
10 USDMF
12 CEP/COS
2 JDMF
6 EU WC
2 KDMF
8 NDC API
25 Listed Suppliers
$ API Reference Price

INTERMEDIATES

18 Intermediate Suppliers

18 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

149 FDF Dossiers, 50 FDA Orange Book, 44 Europe, 15 Canada, 6 Australia, 11 South Africa, 23 Listed Dossiers

149 FDF Dossiers
50 FDA Orange Book
44 Europe
15 Canada
6 Australia
11 South Africa
23 Listed Dossiers

RELATED EXCIPIENT COMPANIES

4 SPI Pharma, 1 DKSH, 5 Faran Shimi Pharmaceutical, 4 Boai NKY Pharmaceuticals Ltd, 5 Gangwal Healthcare, 3 Nanjing Well Pharmaceutical, 6 Actylis, 7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 12 BASF, 7 DFE Pharma, 1 Finar, 9 Gangwal Chemicals, 1 Ideal Cures Pvt Ltd, 4 Ingredion Pharma Solutions, 26 Kerry, 14 Microlex e.U, 1 Nanjing Bold Chemical, 1 Novo Excipients, 3 Pharmatrans-Sanaq, 6 Pluviaendo, 4 Prachin Chemical, 21 Roquette, 7 Seppic, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 11 Sigachi Industries, 1 Ulanqab Kema New Material, 4 Vasa Pharmachem

4 SPI Pharma
1 DKSH
5 Faran Shimi Pharmaceutical
4 Boai NKY Pharmaceuticals Ltd
5 Gangwal Healthcare
3 Nanjing Well Pharmaceutical
6 Actylis
7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
12 BASF
7 DFE Pharma
1 Finar
9 Gangwal Chemicals
1 Ideal Cures Pvt Ltd
4 Ingredion Pharma Solutions
26 Kerry
14 Microlex e.U
1 Nanjing Bold Chemical
1 Novo Excipients
3 Pharmatrans-Sanaq
6 Pluviaendo
4 Prachin Chemical
21 Roquette
7 Seppic
5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd
1 Shanghai Welltone Material Technology Co., Ltd
11 Sigachi Industries
1 Ulanqab Kema New Material
4 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

66 Fillers, Diluents & Binders, 26 Disintegrants & Superdisintegrants, 23 Direct Compression, 19 Granulation, 19 Solubilizers, 17 Thickeners and Stabilizers, 15 Lubricants & Glidants, 14 Co-Processed Excipients, 12 Parenteral, 10 Controlled & Modified Release, 9 Coating Systems & Additives, 8 Film Formers & Plasticizers, 7 Taste Masking, 7 Emulsifying Agents, 6 Topical, 5 Chewable & Orodispersible Aids, 3 API Stability Enhancers, 3 Rheology Modifiers, 2 Surfactant & Foaming Agents, 1 Dry Powder Inhalation

66 Fillers, Diluents & Binders
26 Disintegrants & Superdisintegrants
23 Direct Compression
19 Granulation
19 Solubilizers
17 Thickeners and Stabilizers
15 Lubricants & Glidants
14 Co-Processed Excipients
12 Parenteral
10 Controlled & Modified Release
9 Coating Systems & Additives
8 Film Formers & Plasticizers
7 Taste Masking
7 Emulsifying Agents
6 Topical
5 Chewable & Orodispersible Aids
3 API Stability Enhancers
3 Rheology Modifiers
2 Surfactant & Foaming Agents
1 Dry Powder Inhalation

DIGITAL CONTENT

26 News #PharmaBuzz

26 News #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 47 Regulatory FDF Prices, 3 Annual Reports

1 US Medicaid Prescriptions
47 Regulatory FDF Prices
3 Annual Reports

MARKET PLACE

16 APIs, 22 FDF Dossiers

16 APIs
22 FDF Dossiers

PATENTS & EXCLUSIVITIES

3 US Patents

3 US Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 4 USP, 16 Others

3 EDQM
4 USP
16 Others

$ API Ref.Price (USD/KG) : 154 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

3 All

01 3BAXTER HLTHCARE

filter Patent Number Reset all filters

3 All

01 37635773

filter API Patent Reset all filters

3 All

01 3Blank

filter FDF Patent Reset all filters

3 All

01 3Y

filter Expiration Date Reset all filters

3 All

01 32029-03-13

Product Main Page

01

BAXTER HLTHCARE

AMIODARONE HYDROCHLORIDE

Immuno-Oncology 360

Not Confirmed

BAXTER HLTHCARE

Immuno-Oncology 360

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2029-03-13

AMIODARONE HYDROCHLORIDE

US Patent Number : 7635773

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 22325

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2029-03-13

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

BAXTER HLTHCARE

AMIODARONE HYDROCHLORIDE

Immuno-Oncology 360

Not Confirmed

BAXTER HLTHCARE

Immuno-Oncology 360

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2029-03-13

AMIODARONE HYDROCHLORIDE

US Patent Number : 7635773

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 22325

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2029-03-13

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

BAXTER HLTHCARE

AMIODARONE HYDROCHLORIDE

Immuno-Oncology 360

Not Confirmed

BAXTER HLTHCARE

Immuno-Oncology 360

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2029-03-13

AMIODARONE HYDROCHLORIDE

US Patent Number : 7635773

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 22325

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2029-03-13

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!